Trial Profile
Effects of Inhaled Nitric Oxide on Ischemia-Reperfusion Injury in Human Liver During Transplantation
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Liver injury; Reperfusion injury
- Focus Therapeutic Use
- 27 May 2014 New trial record
- 17 Nov 2009
- 21 Apr 2008